BiotechTube
Home/Armata Pharmaceuticals/Deborah Birx, M.D.
DB

Deborah Birx, M.D.

Chief Executive Officer

Armata Pharmaceuticals

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

Armata Pharmaceuticals Pipeline

DrugIndicationPhase
AP-PA02Pseudomonas aeruginosa infectionsPhase 1/2
AP-PA03Pseudomonas aeruginosa infectionsNot Specified
AP-SA02Staphylococcus aureus infectionsNot Specified